Reye syndrome

22,713views

Reye syndrome

ICS

ICS

Bacterial structure and functions
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Streptococcus agalactiae (Group B Strep)
Clostridium perfringens
Clostridium botulinum (Botulism)
Bacillus cereus (Food poisoning)
Corynebacterium diphtheriae (Diphtheria)
Listeria monocytogenes
Escherichia coli
Shigella
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Yersinia pestis (Plague)
Helicobacter pylori
Neisseria meningitidis
Neisseria gonorrhoeae
Bordetella pertussis (Whooping cough)
Haemophilus influenzae
Mycobacterium tuberculosis (Tuberculosis)
Chlamydia trachomatis
Borrelia burgdorferi (Lyme disease)
Treponema pallidum (Syphilis)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Viral structure and functions
Varicella zoster virus
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Parvovirus B19
Human papillomavirus
Poxvirus (Smallpox and Molluscum contagiosum)
Poliovirus
Rhinovirus
Influenza virus
Mumps virus
Respiratory syncytial virus
Measles virus
Human parainfluenza viruses
Zika virus
West Nile virus
Norovirus
Rotavirus
Coronaviruses
HIV (AIDS)
Rabies virus
Rubella virus
Histoplasmosis
Candida
Aspergillus fumigatus
Cryptococcus neoformans
Plasmodium species (Malaria)
Babesia
Cryptosporidium
Toxoplasma gondii (Toxoplasmosis)
Enterobius vermicularis (Pinworm)
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Pediatric infectious rashes: Clinical
Reye syndrome
Skin cancer: Clinical
Environmental and chemical toxicities: Pathology review
Paracetamol toxicity
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Thyroid nodules and thyroid cancer: Clinical
Herpesvirus medications
Lower urinary tract infection
Urinary tract infections: Pathology review
Urinary tract infections: Clinical
Kidney stones
Renal failure: Pathology review
Diabetes insipidus
Endocrine system anatomy and physiology
Hypopituitarism
Hypertension
Adrenal masses: Pathology review
Blood components
Testosterone
Anemia of chronic disease
Systemic lupus erythematosus (SLE): Clinical
Diarrhea: Clinical
Joint pain: Clinical
Rheumatoid arthritis: Clinical
Chronic kidney disease: Clinical
Diabetes mellitus: Clinical
Diabetic nephropathy
Blistering skin disorders: Clinical
Sexually transmitted infections: Clinical
Pneumonia: Clinical
Pneumonia: Pathology review
Nitrogen and urea cycle
Diabetes mellitus: Pathology review
Viral exanthems of childhood: Pathology review
Cardiac preload
Cardiac afterload
Miscellaneous genetic disorders: Pathology review
Mendelian genetics and punnett squares
Gel electrophoresis and genetic testing

Flashcards

Reye syndrome

0 of 8 complete

Transcript

Watch video only

Content Reviewers

Here’s an example label taken from a pretty common bottle of aspirin, notice that the first warning is “Reye’s syndrome”, and it says that “children or teenagers who are recovering from chicken-pox or flu-like symptoms should not use this product.” Why’s that?

Reye’s syndrome is characterized by encephalopathy, where encephalo refers to the brain and pathy means that the tissue or organ isn’t quite functioning properly, so there’s some change in the way the brain’s functioning.

Reye’s syndrome’s also characterized by liver failure.

This disease is extremely rare, but when it does happen it typically happens in children between the ages of 4 and 12, following an infection like the flu or chicken-pox and is highly associated with the use of aspirin during the infection.

Since this association was found, the incidence of Reye’s syndrome has dropped significantly, and has led to the requirement of the warning seen on the label for aspirin.

Why though, does Reye’s syndrome seem to happen most often when aspirin is taken during an infection in children?

Ultimately the answer to this question is still unknown, what is known is that in patients with Reye’s syndrome the mitochondria inside their liver cells, or hepatocytes, become damaged.

Mitochondria do a few super important things for our cells, right? Including oxidative phosphorylation and fatty-acid beta-oxidation, both of which help provide energy as ATP to the cell.

So mitochondria are the energy producers of the cell, right?

And when the cells can’t generate ATP they can eventually die because they have lose their main source of energy.

Since the liver cells seem to be the main cells targeted in Reye’s disease, the liver becomes one of the main organs affected.

Still, the question of how mitochondria, specifically in hepatocytes, become damaged remains mostly a mystery.

It’s known that salicylates like aspirin are able to uncouple oxidative phosphorylation, which might help to explain their involvement in mitochondrial destruction, however it’s unclear what relationship exists with viral infection, though there certainly seems to be one.

Whatever the case, as the hepatocytes die and the liver becomes dysfunctional, blood doesn’t get filtered, and so it doesn’t get the nitrogen-containing toxins filtered by the liver like it normally would. This leads to increased ammonia in the blood.

Since ammonia is able to diffuse across the blood-brain barrier, it begins to interfere with brain function, causing the characteristic encephalopathy seen as Reye’s disease progresses.

Ammonia appears to mainly target astrocytes, a type of glial cell in the brain, and although the mechanisms aren’t fully understood, ammonia seems to cause astrocyte swelling and oxidative damage.

Key Takeaways

Reye's syndrome is a rare rapidly progressive encephalopathy that usually begins shortly after recovery from an acute viral illness influenza and varicella. It mostly affects children who recently recovered from viral infections, and who used salicylate drugs such as aspirin during the infection period.

Reye's syndrome is a potentially fatal syndrome that has numerous detrimental effects on many organs, especially the brain and liver. Symptoms include sudden onset of vomiting, lethargy, confusion, seizures, and coma. Treatment of Reye's syndrome usually involves careful monitoring and supportive management. Mannitol or glycerol might be given to reduce cerebral edema, and induced hyperventilation might be initiated to help reduce fluid buildup in the brain.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Reye's and Reye's-like syndromes" Cell Biochemistry and Function (2008)
  6. "Aspirin and Reye Syndrome" Pediatric Drugs (2007)